Impact BioMedical Inc.
IBO
$0.8569
-$0.0731-7.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 1.17M | -4.25M | -4.64M | -4.34M | -6.46M |
| Total Depreciation and Amortization | 7.00K | 6.00K | 7.00K | 7.00K | -830.00K |
| Total Amortization of Deferred Charges | 1.11M | 1.11M | 1.11M | 1.11M | 1.95M |
| Total Other Non-Cash Items | -5.73M | -72.00K | 85.00K | -71.00K | 2.17M |
| Change in Net Operating Assets | 352.00K | 717.00K | 887.00K | 436.00K | 392.00K |
| Cash from Operations | -3.10M | -2.48M | -2.55M | -2.85M | -2.78M |
| Capital Expenditure | 0.00 | -1.00K | -13.00K | -18.00K | -294.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.00K | 2.00K | 2.00K | 3.00K | 3.00K |
| Cash from Investing | 3.00K | 1.00K | -11.00K | -15.00K | -291.00K |
| Total Debt Issued | 1.83M | 2.48M | 2.56M | 2.87M | 3.17M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.73M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.56M | 2.48M | 2.56M | 2.87M | 3.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.47M | -1.00K | 1.00K | -1.00K | 100.00K |
